March 2021

NEUROSCIENCES

NORTHWESTERN DRUG KILLS GLIOBLASTOMA TUMOR CELLS WITH PRIYA KUMTHEKAR, MD

Featuring: Priya Kumthekar, MD

Episode Summary

An early clinical trial found that a spherical nucleic acid drug developed at Northwestern kills tumor cells in people with the fatal brain cancer glioblastoma. This is the first time a nanotherapeutic has been shown to cross the blood-brain barrier and cause cell death. Lead investigator Priya Kumthekar, MD, explains the results of the study.

Continuing Medical Education Credit

​Physicians who listen to this podcast may claim continuing medical education credit after listening to an episode of this program.

This podcast was originally release via the Feinberg School of Medicine News Center in March 2021.
Priya Kumthekar, MD
  • Associate Professor of Neurology in the Division of Neuro-oncology 
  • Associate Professor of Medicine in the Division of Hematology and Oncology
  • Member of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University
  • Member of Northwestern University Clinical and Translational Sciences Institute

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like